IRIS
CHIARANTINI, LAURA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.170
EU - Europa 7.315
AS - Asia 4.054
SA - Sud America 382
AF - Africa 37
OC - Oceania 22
Continente sconosciuto - Info sul continente non disponibili 12
Totale 21.992
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.078
GB - Regno Unito 2.662
CN - Cina 2.182
IT - Italia 1.243
UA - Ucraina 1.057
SG - Singapore 1.050
SE - Svezia 622
FI - Finlandia 429
DE - Germania 416
TR - Turchia 392
RU - Federazione Russa 379
BR - Brasile 288
IE - Irlanda 213
VN - Vietnam 144
FR - Francia 100
IN - India 75
CA - Canada 61
KR - Corea 43
AR - Argentina 35
ES - Italia 35
BE - Belgio 33
PL - Polonia 33
HK - Hong Kong 24
EC - Ecuador 22
NL - Olanda 21
BD - Bangladesh 20
JP - Giappone 19
MX - Messico 19
AU - Australia 17
IR - Iran 13
EU - Europa 10
SA - Arabia Saudita 10
AT - Austria 9
CO - Colombia 9
ID - Indonesia 9
MA - Marocco 9
PY - Paraguay 9
PK - Pakistan 8
TG - Togo 8
ZA - Sudafrica 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
EE - Estonia 7
CL - Cile 6
LT - Lituania 6
UZ - Uzbekistan 6
CZ - Repubblica Ceca 5
JO - Giordania 5
KE - Kenya 5
NZ - Nuova Zelanda 5
VE - Venezuela 5
AZ - Azerbaigian 4
BG - Bulgaria 4
DK - Danimarca 4
HN - Honduras 4
IL - Israele 4
KZ - Kazakistan 4
LA - Repubblica Popolare Democratica del Laos 4
PA - Panama 4
PE - Perù 4
SK - Slovacchia (Repubblica Slovacca) 4
BO - Bolivia 3
KG - Kirghizistan 3
LU - Lussemburgo 3
LV - Lettonia 3
PT - Portogallo 3
TH - Thailandia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BN - Brunei Darussalam 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CY - Cipro 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
IQ - Iraq 2
KH - Cambogia 2
LK - Sri Lanka 2
MY - Malesia 2
NP - Nepal 2
PS - Palestinian Territory 2
RO - Romania 2
AL - Albania 1
BH - Bahrain 1
CR - Costa Rica 1
DZ - Algeria 1
ET - Etiopia 1
HR - Croazia 1
IM - Isola di Man 1
IS - Islanda 1
MD - Moldavia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
NI - Nicaragua 1
NO - Norvegia 1
OM - Oman 1
PH - Filippine 1
Totale 21.987
Salva come PNG Salva come JPEG
Città #
Southend 2.440
Fairfield 1.049
Woodbridge 1.046
Jacksonville 861
Houston 857
Ashburn 848
Chandler 689
Ann Arbor 659
Cambridge 473
Nanjing 460
Singapore 460
Seattle 444
Wilmington 396
Dallas 351
Izmir 309
Beijing 256
Urbino 234
Boardman 214
Dublin 213
Nanchang 168
Helsinki 165
New York 150
San Mateo 129
Los Angeles 127
Princeton 125
Shenyang 99
Jiaxing 86
Moscow 86
Hebei 82
Tianjin 81
Düsseldorf 79
Munich 71
Changsha 68
Mülheim 56
Jinan 55
Kunming 51
Shanghai 51
San Diego 49
Ho Chi Minh City 46
Istanbul 45
Milan 45
San Francisco 43
Bremen 42
Council Bluffs 41
Ancona 40
Guangzhou 37
Buffalo 35
São Paulo 34
Frankfurt am Main 33
London 32
Santa Clara 32
Seongnam 30
Brussels 29
Hangzhou 28
Toronto 27
Velikiy Novgorod 27
Rome 25
Hanoi 24
Ningbo 24
Turku 24
Warsaw 22
Zhengzhou 22
Denver 21
Des Moines 19
Hong Kong 19
Stockholm 19
Taizhou 18
Tokyo 16
Boston 15
Brooklyn 15
Chennai 15
Atlanta 14
Bologna 14
Chicago 14
Dong Ket 14
Lanzhou 13
Orem 13
Poplar 13
Rio de Janeiro 12
Auburn Hills 10
Fuzhou 10
Mumbai 10
Perugia 10
Phoenix 10
Turin 10
Bellaria-Igea Marina 9
Haikou 9
Melbourne 9
Mergo 9
Montreal 9
Norwalk 9
Osimo 9
Querétaro 9
Shenzhen 9
Changchun 8
Guayaquil 8
Kraków 8
Lomé 8
Nuremberg 8
Quito 8
Totale 15.277
Salva come PNG Salva come JPEG
Nome #
Targeting SARS-CoV-2 by synthetic dual-acting thiol compounds that inhibit Spike/ACE2 interaction and viral protein production 511
Glutathione Depletion Is Linked with Th2 Polarization in Mice with a Retrovirus-Induced Immunodeficiency Syndrome, Murine AIDS: Role of Proglutathione Molecules as Immunotherapeutics 401
In vitro effects on calcium oxalate crystallization kinetics and crystal morphology of an aqueous extract from Ceterach officinarum: analysis of a potential antilithiatic mechanism 286
Chitosan Nanoparticles for Topical Co-Administration of the Antioxidants Glutathione and Idebenone: Characterization and In Vitro Release 283
Bacteria-produced ferric exopolysaccharide nanoparticles as iron delivery system for truffles (Tuber borchii) 274
Inhibition of murine AIDS by pro-glutathione (GSH) molecules 262
Design, synthesis and biological activity of hydrogen peroxide responsive arylboronate melatonin hybrids 261
2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line 260
2',3'-Dideoxycytidine induced drug resistance in human cells 254
Pharmacokinetic and antiretroviral activity in mice of oral [P(1),P(2)-bis[2-(adenin-9-yl)ethoxymethyl]phosphonate], a prodrug of 9-(2-phosphonylmethoxyethyl)adenine 251
A versatile vector system for generating recombinant EGFP-tagged proteins in yeast 244
Erythrocyte-based drug delivery 236
2',3'-Dideoxycytidine induced drug-resistance in human cells 234
Drug delivery through phagocytosis of red blood cells 233
Characterization and complementation of a Fus3/Kss1 type MAPK from Tuber borchii, TBMK 231
Macrophage protection by addition of glutathione (GSH)-loaded erythrocytes to AZT and DDI in a murine AIDS model. 224
Comparison of novel delivery systems for antisense peptide nucleic acids 223
Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate 222
Inhibition of macrophage iNOS by selective targeting of antisense PNA. 220
Enhanced antisense effect of modified PNAs delivered through functional PMMA microspheres 217
Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS. 214
Glucose metabolism in fibroblasts from patients with erythrocyte hexokinase deficiency. 209
Repeated cycles of alternate administration of fludarabine and zidovudine plus didanosine inhibits murine AIDS and reduces proviral DNA content in lymph nodes to undetectable levels 208
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 206
Inhibition of murine AIDS by reduced glutathione. 204
Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application 204
Development of a multilevel approach for the evaluation of nanomaterials toxicity 204
ATP modifications in hexokinase deficient fibroblasts exposed to nutrient shifts. 203
A Dinuclear Copper(II) Complex as Nitric Oxide Trapper in a Stimulated Murine Macrophage Model 200
Cloning and expression of a new human polypeptide which regulates protein phosphorylation in Escherichia coli 199
Red blood cells as glucocorticoids delivery system. 196
Dinuclear Copper (II) complex as nitric oxide scavenger in stimulated murine macrophage model 192
New treatment protocol including lympholytic and antiretroviral drugs to inhibit murine AIDS 191
Simultaneous extraction and reverse-phase high-performance liquid chromatographic determination of adenine and pyridine nucleotides in human red blood cells 191
Red blood cell phagocytosis and lysis following oxidative damage by phenylhydrazine. 188
Simultaneous extraction and HPLC determination of ATP, ADP, AMP, NADP+ NADPH, NAD+ and NADH in human red blood cells. 187
The use of Eudragit RS 100/cyclodextrin nanoparticles for the transmucosal administration of glutathione. 187
Glucose 1,6-diphosphate in the erythrocytes of various species of mammal 187
Core-shell nanospheres for oligonucleotide delivery. V: adsorption/release behavior of 'stealth' nanospheres 185
Heat stress-activated, calcium dependent nitric oxide synthase in sponges 185
Purification, properties, and evidence for two subtypes of human placenta hexokinase type I. 184
AIDS vaccination studies using an ex vivo feline immunodeficiency virus model: homologous erythrocytes as a delivery system for preferential immunization with putative protective antigens 183
CYTOTOXICITY OF NANOPARTICLES 180
CYTOTOXICITY AND PROINFLAMMATORY ACTIVITY OF DIESEL AND BIO-DIESEL EXHAUST PARTICLE ON HUMAN KERATINOCYTES. 179
Bioreactivity and biocompatibility of a vitamin E-modified multi-layer hemodialysis filter 179
Immunological quantification of human hexokinase type I 178
Human erythrocyte hexokinases are immunologically related 178
Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides 176
Inhibition of murine AIDS by combination of AZT and DDCTP-loaded erythrocytes 176
Red blood cell phagocytosis following hexokinase inactivation. 175
TOXICITY COMPARISON OF DIESEL EXHAUST PARTICLE (DEP) FROM AN URBAN BUS ENGINE FUELLED WITH DIESEL OIL AND 'BIODIESEL' BLEND. 174
Red blood cells as a glucocorticoids delivery system 173
Preparation and characterization of monoclonal antibodies to human hexokinase type I. 172
A New Dinuclear Copper(II) Complex to Trap Nitric Oxide 171
Inhibition of murine AIDS by a new azidothymidine homodinucleotide 170
Inhibition of Murine AIDS by a New Azidothymidine Homodinucleotide. 169
Human erythrocytes phosphoglucomutase: comparison of the kinetic properties of PGM1 and PGM2 isoenzymes 169
Esocinasi in fibroblasti umani. 168
Targeting dexamethasone to macrophages. 168
Modulated red blood cell survival by membrane protein clustering 168
Metabolism, mitochondrial uptake and toxicity of 2’,3’-dideoxycytidine 166
The interaction of phosphorylated sugars with human hexokinase I. 164
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 164
Liposomes as carriers of the antiretroviral agent dideoxycytidine-5'-triphosphate. 163
Il glucoso 1,6 difosfato negli eritrociti di differenti specie di mammifero 161
Red blood cell mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat protein in mice induces anti-Tat neutralizing antibodies and CTL. 158
Role of hexokinase in the regulation of glucose metabolism in human erythrocytes. 155
Studi preliminari sull’effetto proinfiammatorio in cheratinociti umani della porzione idrosolubile del particolato atmosferico frazionato. 155
Erythrocytes as carriers of reduced glutathione (GSH) in the treatment of retroviral infections 155
Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice 154
Red blood cells as an antigen-delivery system. 152
Effetto dell'età sulla sopravvivenza degli eritrociti di topo. 151
In vitro and in vivo toxicity of 2',3'-dideoxycytidine in mice 151
Immunological studies on mammalian hexokinase 150
Red blood cells as carriers of drugs against retroviruses 150
Inhibition of murine AIDS by alternate administration of azidothimidine and fludarabine monofosfate. 150
In vivo survival and in vitro phagocytosis of engineered erythrocytes. 149
Vaccination strategy using red blood cells as antigen delivery system. 147
Molecular basis of the 2',3'-dideoxycytidine induced drug-resistance in human cells 147
In vitro evaluation of nanomaterials toxicity 146
Similarities and differences between human and rat hexokinases type I. 146
High production of secondary metabolites and biological activities of Cydonia oblonga Mill. pulp fruit callus 145
Molecular basis of 2',3'-dideoxycytidine-induced drug resistance in human cells. 143
Immunological studies on mammalian hexokinase. 141
New drug combinations for the treatment of murine AIDS and macrophage protection. 141
Use of fluorescent probes for describing the process of encapsulation by hypotonic dialysis. 140
Introduction to in vivo targeting. 139
Rabbit red blood cell hexokinase. Decay mechanism during reticulocyte maturation. 137
Disparities in Cancer Incidence in Armenia, 2013-2016: Setting Priorities for Preventive Interventions. 137
Role of macrophage protection in the development of murine AIDS. 136
In vitro targeting of doxorubicin loaded canine erythrocytes to cytotoxic T-lymphocytes (CTLL). 135
Vie degradative del glucoso 1,6 difosfato negli eritrociti umani. 135
Immobilization of enzymes and proteins on red blood cells. 133
Antinsense peptide nucleic acid delivered by core-shell microspheres. 133
New delivery systems for antisense Peptide Nucleic Acids. 131
Role of macrophage protection in the development of murine AIDS 131
Inhibition of murine retrovirus induced immunodeficiency by nucleoside analogues and combination therapy. 130
Immobilization of enzymes and proteins on red blood cells. 129
NUCLEIC ACIDS AND PROTEIN DELIVERY THROUGH POLYMERIC CORE-SHELL NANOSPHERES 126
Bilancio di genere 2022 121
Totale 18.554
Salva come PNG Salva come JPEG
Categoria #
all - tutte 76.590
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 76.590
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.333 0 0 0 0 0 175 99 163 319 170 294 113
2021/20221.277 80 120 157 191 40 46 56 73 82 65 23 344
2022/20232.475 235 104 40 225 194 456 7 152 537 137 277 111
2023/2024653 74 39 38 65 46 162 22 67 8 59 19 54
2024/20252.279 102 109 496 157 69 160 269 115 245 169 221 167
2025/20262.850 436 509 564 928 387 26 0 0 0 0 0 0
Totale 22.146